Form 4 for EYPT EyePoint, Inc.
Accepted 2024-01-29 00:00:00 ET · period of report 2024-01-25 · accession 0001562180-24-000784 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-01-29 | 2024-01-25 | EYPT | Paggiarino Dario A. | Chief Medical Off | M - OptEx | $13.02 | +600 | 37.1K | +2% | +$7,809 |
| DMT | 2024-01-29 | 2024-01-25 | EYPT | Paggiarino Dario A. | Chief Medical Off | S - Sale+OE | $25.00 | -600 | 36.8K | -2% | -$15.0K |
| DMT | 2024-01-29 | 2024-01-25 | EYPT | Paggiarino Dario A. | Chief Medical Off | M - OptEx | $0.00 | -600 | 16.6K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-25 | M | A | 300 | $13.13 | 36,805 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-25 | S | D | 300 | $25.00 | 36,505 | D | — | — | |
| 3 | Common | Common Stock | 2024-01-25 | S | D | 300 | $25.00 | 36,805 | D | — | — | |
| 4 | Common | Common Stock | 2024-01-25 | M | A | 300 | $12.90 | 37,105 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-01-25 | M | D | 300 | $0.00 | 51,304 | D | $13.13 · — to 2031-02-09 | 300 Common Stock | (F1) The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2022 and the remainder ratably, on a monthly basis, over the remaining three years. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-01-25 | M | D | 300 | $0.00 | 16,635 | D | $12.90 · — to 2030-02-28 | 300 Common Stock | (F2) The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which began March 28, 2020 |